180 Life Sciences Corp. (NASDAQ: ATNF)
$2.08
-0.0500 ( -2.35% ) 128.5K
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
Market Data
Open
$2.08
Previous close
$2.13
Volume
128.5K
Market cap
$1.91M
Day range
$2.00 - $2.28
52 week range
$1.31 - $21.28
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | Jul 02, 2024 |
| 8-k | 8K-related | 14 | May 21, 2024 |
| 10-q | Quarterly Reports | 62 | May 15, 2024 |
| 8-k | 8K-related | 14 | May 15, 2024 |
| 8-k | 8K-related | 20 | May 09, 2024 |
| 10-k/a | Quarterly Reports | 17 | Apr 29, 2024 |
| 8-k | 8K-related | 17 | Apr 19, 2024 |
| 10-k | Annual reports | 101 | Mar 25, 2024 |
| 8-k | 8K-related | 16 | Mar 14, 2024 |
| 3 | Insider transactions | 1 | Mar 12, 2024 |